On this page
Your diagnosis paperwork, not just your antipsychotic rate, is the quality-measure exposure
Skilled Nursing News reported in September 2026 that two nursing-home clinical leaders expect rising behavioral health needs to collide with renewed antipsychotic oversight. Cory Woods, chief clinical officer at California-based Rockport Healthcare Services, said residents judged misdiagnosed in an audit can suppress a facility's quality measures (QMs). Lisa Chubb, chief nursing officer at Venza Care, forecast a "tsunami" of problems from unprepared operators. The backdrop is an Office of Inspector General (OIG) work plan on antipsychotic misuse in March and a CMS schizophrenia audit.
What are auditors actually looking at?
Two things: an OIG work plan item from March on antipsychotic misuse, and a CMS audit of schizophrenia diagnoses that may have been wrong, whether made in the nursing home or in a hospital.
Hospitals, the article notes, operate under less stringent prescribing rules, so a questionable diagnosis can arrive with the resident. Your admission paperwork is therefore part of your exposure. The piece also offers a lead-time estimate for auditor activity without saying who measured it, so don't build a calendar on it.
How does a diagnosis problem reach your quality measures?
According to Woods, if surveyors audit and conclude residents were misdiagnosed, that finding can suppress a facility's quality measures in totality.
Behavioral acuity also spills into other outcomes. Woods's example: a resident with a psychiatric condition who is up at night with poor balance raises the odds of falls with injury. His answer is interprofessional comprehensive care planning.
How much of this is evidence rather than opinion?
Mostly opinion. The reporting we reviewed rests on two executives' expectations and offers no counts of misdiagnosed residents, no QM data and no audit results.
Chubb's forecast is not a measurement. Woods's QM mechanism is one operator's reading of audit consequences, and the article cites no CMS document for it. His reimbursement case comes from an operator that went back to its payers over resources. It leans on Cal AIM, a California Department of Health Care Services initiative supporting the behavioral health of Medi-Cal beneficiaries. Readers elsewhere cannot assume an equivalent exists.
What should a Director of Nursing do now?
Woods suggests screening for complex behavioral needs before admission, extending activities hours, and training staff in crisis intervention and de-escalation. Our addition: audit every antipsychotic diagnosis against its documentation.
Each item consumes leadership time and staff hours, so this is a staffing and retention question as much as a clinical one. It connects to our earlier Watch item on nurse leadership under pressure, crisis and scrutiny.
Ask your EHR and consultant pharmacy partners to list every resident on an antipsychotic with the diagnosis, who made it, where, and the supporting documentation. Ask any vendor promising a quality-measure benefit who measured it, and on which residents.
Frequently asked questions
Does a schizophrenia diagnosis count affect audit eligibility?
Yes, per the article: having a certain amount of schizophrenia diagnoses bars a facility from the recently introduced risk-based audit program. The reporting we reviewed does not state the threshold.
Is the OIG work plan a finding against my facility?
No. The article treats it as a possible signal of future scrutiny, not a finding about any provider.
Will Cal AIM help my facility outside California?
Not directly. It is a California initiative for Medi-Cal beneficiaries, and the article names no equivalent elsewhere. Ask your state association what exists.
Sources: Skilled Nursing News